Your browser doesn't support javascript.
loading
Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes.
Chen, H-H; Lin, C-L; Yeh, S-Y; Kao, C-H.
Afiliação
  • Chen HH; From the Institute of Public Health and Medicine, Chung Shan Medical University, Taichung, Taiwan, Division of Metabolism & Endocrinology, Changhua Christian Hospital, Changhua, Taiwan, Division of Metabolism & Endocrinology, Nantou Christian Hospital, Nantou, Taiwan.
  • Lin CL; Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan, College of Medicine, China Medical University, Taichung, Taiwan.
  • Yeh SY; Division of Metabolism & Endocrinology, Nantou Christian Hospital, Nantou, Taiwan, Department of Healthcare Administration, Asia University, Taichung, Taiwan.
  • Kao CH; Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan and Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan d10040@mail.cmuh.org.tw.
QJM ; 109(2): 91-5, 2016 Feb.
Article em En | MEDLINE | ID: mdl-25991869

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Herpes Zoster Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Herpes Zoster Idioma: En Ano de publicação: 2016 Tipo de documento: Article